Can a nap stop a migraine attack, or is it a trigger? It might depend — learn expert tips to leverage sleep effectively for ...

Nuvie Bio, a new clinical-stage biopharmaceutical company dedicated to addressing the most pressing unmet medical needs in migraine and related neurological diseases, announced completion of a ...

Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration (FDA) recently assigned a Prescription Drug User Fee Act (PDUFA) goal date of ...

Researchers found extended phone use was one of two habits associated with the increased risk of this painful condition.

Pfizer has raised the price of Paxlovid, the anti-COVID medicine, by 3 per cent, the migraine treatment, Nurtec, and cancer ...

A Reuters analysis of prices for new drugs found that pharmaceutical companies launched new U.S. drugs in ... As well as a 3% hike on Paxlovid, the company raised prices on medicines including ...

Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.

This new evidence review was funded by AbbVie, the maker of Qulipta. Qulipta and other CGRP-blocking drugs tend to be much more expensive than older migraine drugs, according to the Association of ...

Pediatric migraine medications, including topiramate and pregabalin ... randomized clinical trials to confirm these findings and explore new avenues for enhancing care in pediatric migraine ...

New York, and colleagues examined improvements in efficacy and functional outcomes in the first 4 weeks of treatment with atogepant 60mg once daily for the preventive treatment of migraine.

A drug recently approved to prevent migraine may start working right away, according to a study published online issue of Neurology, the medical journal of the American Academy of Neurology. The study ...

“With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks ...